RANI · Rani Therapeutics Holdings, Inc. · Documents
Market Cap
$117.45M
Shares
139.40M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| Investor Event Transcript | 2026-08-12 | 2026-09-30 | |
| 8-K | 2026-08-04 | 2026-08-01 | |
| 8-K | 2026-06-30 | 2026-06-24 | |
| 8-K | 2026-05-29 | 2026-05-28 | |
| 8-K | 2026-05-27 | 2026-05-26 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-15 | 2026-05-11 | |
| DEF 14A | 2026-04-16 | 2026-05-28 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-26 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-01-02 | 2025-12-31 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-27 | 2025-10-22 | |
| 8-K | 2025-10-17 | 2025-10-16 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-16 | 2025-07-14 | |
| 8-K | 2025-06-26 | 2025-06-20 | |
| 8-K | 2025-05-29 | 2025-05-28 | |
| 8-K | 2025-05-20 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-06 | 2025-05-01 | |
| 8-K | 2025-04-30 | 2025-04-24 | |
| DEF 14A | 2025-04-16 | 2025-05-28 | |
| 8-K | 2025-04-09 | 2025-04-07 | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-10-16 | 2024-10-15 | |
| 8-K | 2024-09-11 | 2024-09-10 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-07-23 | 2024-07-22 | |
| 8-K | 2024-07-12 | — | |
| 8-K | 2024-06-24 | 2024-06-17 | |
| 8-K | 2024-05-30 | 2024-05-29 | |
| 8-K | 2024-05-06 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| DEF 14A | 2024-04-17 | 2024-05-29 | |
| 8-K | 2024-03-20 | — | |
| 10-K | 2024-03-20 | 2023-12-31 | |
| 8-K | 2024-02-05 | — | |
| 8-K | 2023-12-19 | 2023-12-16 | |
| 8-K | 2023-12-14 | — |
Showing 1–50 of 91 filings
Key facts
CIK
1856725
CUSIP
753018100
13F (30d)
22 filings
22 filers
Visit website
Investor relations